These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 15367860)

  • 21. Dermatomyositis. Diagnosis and evaluation of dermatomyositis, polymyositis, and inclusion-body myositis.
    Krajnc I
    Adv Exp Med Biol; 1999; 455():181-6. PubMed ID: 10599341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inflammatory myopathies].
    Cherin P
    Rev Prat; 2001 Feb; 51(3):270-7. PubMed ID: 11265423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Idiopathic myositis].
    Burgunder JM
    Ther Umsch; 2003 Jul; 60(7):407-12. PubMed ID: 12956034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
    Eymard B
    Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inflammatory muscle diseases: dermatomyositis, polymyositis, and inclusion body myositis].
    Genth E
    Internist (Berl); 2005 Nov; 46(11):1218-32. PubMed ID: 16200404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
    Choi YC; Dalakas MC
    Neurology; 2000 Jan; 54(1):65-71. PubMed ID: 10636127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis, and dermatomyositis.
    Askanas V; Engel WK; Mirabella M
    Curr Opin Neurol; 1994 Oct; 7(5):448-56. PubMed ID: 7804466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymyositis: an overdiagnosed entity.
    van der Meulen MF; Bronner IM; Hoogendijk JE; Burger H; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; de Visser M
    Neurology; 2003 Aug; 61(3):316-21. PubMed ID: 12913190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis.
    Dalakas MC; Sivakumar K
    Curr Opin Neurol; 1996 Jun; 9(3):235-9. PubMed ID: 8839618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymyositis: not a unicorn or mythological beast...but maybe a duck?
    Kissel JT
    Neurology; 2008 Feb; 70(6):414-5. PubMed ID: 18250286
    [No Abstract]   [Full Text] [Related]  

  • 31. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inclusion body myositis: clinical and pathological boundaries.
    Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
    Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis.
    Schneider C; Gold R; Dalakas MC; Schmied M; Lassmann H; Toyka KV; Hartung HP
    J Neuropathol Exp Neurol; 1996 Dec; 55(12):1205-9. PubMed ID: 8957443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of action of intravenous immunoglobulin in inflammatory muscle disease.
    Quick A; Tandan R
    Curr Rheumatol Rep; 2011 Jun; 13(3):192-8. PubMed ID: 21503696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies.
    Wiendl H; Mitsdoerffer M; Schneider D; Melms A; Lochmuller H; Hohlfeld R; Weller M
    Brain; 2003 May; 126(Pt 5):1026-35. PubMed ID: 12690043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of cytokines and chemokines in idiopathic inflammatory myopathies.
    De Paepe B; Creus KK; De Bleecker JL
    Curr Opin Rheumatol; 2009 Nov; 21(6):610-6. PubMed ID: 19726994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features.
    Khan S; Christopher-Stine L
    Rheum Dis Clin North Am; 2011 May; 37(2):143-58, v. PubMed ID: 21444016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymyositis mediated by T lymphocytes that express the gamma/delta receptor.
    Hohlfeld R; Engel AG; Ii K; Harper MC
    N Engl J Med; 1991 Mar; 324(13):877-81. PubMed ID: 1705662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory myopathies.
    Amato AA; Greenberg SA
    Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1615-33. PubMed ID: 24305450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 64th ENMC International Workshop: therapeutic approaches to dermatomyositis, polymyositis, and inclusion body myositis29-31 January 1999, Naarden, The Netherlands.
    Müller-Felber W; Pongratz D; Reimers C
    Neuromuscul Disord; 2001 Jan; 11(1):88-92. PubMed ID: 11166170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.